The same group found that Abeta increased in the brain of the APP23 mouse AD model of AD following inhibition of Cyp46a1 expression, one of the cholesterol transporters (Figure 2; Djelti et al., 2015). Here, CYP46A1 is linked to Alzheimer disease.